People channel feed – Endpoints News

People channel feed

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

2 days ago

Updated: Eikon Therapeutics cuts staff for the second time in less than two years

4 days ago

Exclusive: Weight loss startup Calibrate swaps CEOs in latest leadership shakeup

5 days ago

Prime Medicine sidelines only clinical program, replaces CEO and lays off some staff

6 days ago

Updated: Novo Nordisk CEO to step down amid stock decline, timeline for successor unknown

Last week

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

Last week

UnitedHealth Group CEO Andrew Witty steps down

Last week

Updated: To spin off or not to spin off? Galapagos backpedals on separation plans, CEO Paul Stoffels exits early

Last week

Bayer starts 2025 by cutting 2,000 jobs as it homes in on year-end rehaul target

Last week

AI-focused biotech insitro cuts 22% of staff, citing 'tumultuous market'

3 weeks ago

Blood cancer biotech Vor Bio ends clinical work, lays off 95% of staff

3 weeks ago

Europe pledges €500M to attract global science talent

3 weeks ago

Exclusive: Degradation startup raises $39M for pivot to PROTACs and clinical entry

3 weeks ago

Bristol Myers to lay off over 500 workers in New Jersey

3 weeks ago

Bristol Myers to close cell therapy site in Illinois as part of ongoing cost cuts

4 weeks ago

Exits continue at FDA, as more staff in drug office follow fired colleagues out the door

4 weeks ago

The Endpoints Slack interview: Arc Institute's Patrick Hsu on investing, AI and new ways of research

4 weeks ago

Octagon Therapeutics shuts down after 'unresolved biology questions'

4 weeks ago

Scholar Rock names new CEO, adds biotech veterans in C-suite rebuild

4 weeks ago

Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient

5 weeks ago

AstraZeneca CEO says Europe is 'falling behind' on R&D and manufacturing investments

Last month

With aims to become a 'generational biotech,' Zealand Pharma hires Lilly veteran as science chief

Last month

Galapagos CEO Paul Stoffels to step down, former Neumora chief to lead spinout

Last month

Roivant brings rare disease program closer as Immunovant CEO retires

Last month

12 3 4 Next page Last page